Moderna (MRNA) shares jumped 10.1% ... by the biotech firm's stock this week after Oracle (ORCL) co-founder Larry Ellison ...

According to a 2023 PwC report, the AI market in healthcare was valued at $11 billion and is expected to grow to $188 billion by 2030. On January 21st, Oracle Co-founder Larry Ellison said during a ...

Robby Soave and Niall Stanage weigh in on debate of using A.I. to develop mRNA vaccines to target cancer. #AI #mrnavaccines ...

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...

Some of the biggest names in technology have clashed after President Donald Trump unveiled his $500 billion private AI investment project.

Moderna stock has fallen over the past four years, but shares got a boost on positive comments about AI. Is MRNA stock a buy ...

President Donald Trump announced a $500billion investment for private companies to develop artificial intelligence tools to ...

OpenAI and SoftBank (SFTBY) will commit $19B each to the artificial intelligence-focused Stargate Project, The Information ...

Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the ...

Tesla (TSLA) and SpaceX CEO Elon Musk said OpenAI, Oracle (ORCL) and Softbank (SFTBY) “don’t actually have the money” to back up their pledge ...

At the launch of Stargate Project, Oracle's Ellison said that AI could assist in identifying the cancer fragments early ...

Oracle chairman Larry Ellison has announced that AI will soon develop customised mRNA vaccine against cancer for every individual within 48 hours.